Product Information
TEMAZEPAM 30 MG CAPSULE is a generic product labeled by Amneal Pharmaceuticals of New York LLC, priced at $0.0922 per EA under NDC 53746055701. Its NADAC has been published 18 times since Feb 25, 2026.
Strength
30 mg/1
Manufacturer
Amneal Pharmaceuticals of New York LLCNDC
53746055701
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
TEMAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA203482On Market Since
2/19/2024
Pharmacological Classes
Price Statistics
The NADAC for TEMAZEPAM 30 MG CAPSULE has been published 18 times since Feb 25, 2026, and over the history we have for it it has risen 2.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0922 per EA |
|---|---|
| All-time high | $0.0925 (Jun 10, 2026) |
| All-time low | $0.0899 (Feb 25, 2026) |
| 52-week high | $0.0925 |
| 52-week low | $0.0899 |
| Median price | $0.0922 |
| Average price | $0.0915 |
| Largest weekly change | +1.4% (Apr 22, 2026) |
| Weeks tracked | 18 |
| Tracking since | Feb 25, 2026 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TEMAZEPAM 30 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TEMAZEPAM 30 MG CAPSULE, manufactured by Amneal Pharmaceuticals of New York LLC, is $0.0922 per EA (NDC 53746055701), effective Jun 24, 2026.
How has the price of TEMAZEPAM 30 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TEMAZEPAM 30 MG CAPSULE has risen 2.5%. It has been tracked across 18 weekly CMS publications since Feb 25, 2026.
What are the highest and lowest recorded NADAC prices for TEMAZEPAM 30 MG CAPSULE?
Since Feb 25, 2026, the NADAC for TEMAZEPAM 30 MG CAPSULE has ranged from a low of $0.0899 (Feb 25, 2026) to a high of $0.0925 (Jun 10, 2026), with a median of $0.0922 per EA.
Are there cheaper alternatives to TEMAZEPAM 30 MG CAPSULE?
2 NADAC-published products share the same active ingredient, strength, and dosage form as TEMAZEPAM 30 MG CAPSULE, but none are currently priced below it.
Who manufactures TEMAZEPAM 30 MG CAPSULE?
TEMAZEPAM 30 MG CAPSULE (NDC 53746055701) is labeled by Amneal Pharmaceuticals of New York LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification